Nonacute effects of H-FABP deficiency on skeletal muscle glucose uptake in vitro.
Journal
  American journal of physiology. Endocrinology and metabolism.
Citation
  Am J Physiol Endocrinol Metab. 287(5):E977-82
Publication date
  2004 Nov
Authors
  Erol E
Cline GW
Kim JK
Taegtmeyer H
Binas B
Investigators
  Jason K. Kim
Grant agencies
  National Institute of Diabetes and Digestive and Kidney Diseases
Grants
  NIDDK U24-DK-59635
MeSH headings
  Carrier Proteins
Fatty Acids
Glucose
Insulin
Muscle, Skeletal
MeSH qualifiers
  physiology
metabolism
pharmacokinetics
Abstract
  Heart-type fatty acid-binding protein (H-FABP) is required for high rates of skeletal muscle long-chain fatty acid (LCFA) oxidation and esterification. Here we assessed whether H-FABP affects soleus muscle glucose uptake when measured in vitro in the absence of LCFA. Wild-type and H-FABP null mice were fed a standard chow or high-fat diet before muscle isolation. With the chow, the mutation increased insulin-dependent deoxyglucose uptake by 141% (P < 0.01) at 0.02 mU/ml of insulin but did not cause a significant effect at 2 mU/ml of insulin; skeletal muscle triglyceride and long-chain acyl-CoA (LCA-CoA) levels remained normal. With the high-fat diet, the mutation increased insulin-dependent deoxyglucose uptake by 190% (P < 0.01) at 2 mU/ml of insulin, thus partially preventing insulin resistance, and it completely prevented the threefold (P < 0.001) diet-induced increase of muscle triglyceride levels; however, muscle LCA-CoA levels showed little or no reduction. With both diets, the mutation reduced the basal (insulin-independent) soleus muscle deoxyglucose uptake by 28% (P < 0.05). These results establish a close relation between FABP-dependent lipid pools and insulin sensitivity and indicate the existence of a nonacute, antagonistic, and H-FABP-dependent fatty acid regulation of basal and insulin-dependent muscle glucose uptake.